Abstract

NK cells can kill antibody-coated target cells following engagement of FcγRIIIA, the major activating FcγR expressed by these cells. The presence of FcγRIIC (CD32C) has also been reported, but its contribution to the FcγR-dependent effector functions of NK cells remains debated. We demonstrate here that inhibitory FcγRIIB is also expressed by a small subset of CD56+/NKp46+ NK cells and can efficiently down-modulate their FcγR-dependent effector function. Immunofluorescence analyses of NK cells from 52 healthy donors showed the presence of CD56bright/FcγRII (5.2%±3.4), CD56dim/FcγRIIlo/- (94.1%±3.4), and CD56dim/FcγRIIbright (0.64%±0.72) cells. QRT-PCR and protein analyses performed on isolated FcγRIIbright NK cells indicated that FcγRIIB is strongly expressed by these cells but not by FcγRIIlo/- cells. In addition, FcγRIIbright cells showed a weaker antibody-dependent degranulation when incubated with IgG-coated target cells compared with FcγRIIlo/- NK cells, although a strong FcγRIIIA expression was detected in both cells. Furthermore, the addition of anti-FcγRII Fab paralleled a higher degranulation of FcγRIIbright NK cells, indicating a direct role for FcγRIIB in this down-modulating effect. Thus, it is proposed that FcγRIIBbright NK cells represent a new NK cell compartment able to down-modulate NK cell functions triggered by the engagement of activating FcγR.

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://dbpia.nl.go.kr/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
You do not currently have access to this article.